Literature DB >> 11042239

Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry.

M R Shah1, C B Granger, B A Bart, J J McMurray, M C Petrie, E L Michelson, G E Tudor, K Swedberg, L W Stevenson, R M Califf, M A Pfeffer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042239     DOI: 10.1016/s0002-9343(00)00529-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.

Authors:  Willeke N Kasje; Petra Denig; Roy E Stewart; Pieter A de Graeff; Flora M Haaijer-Ruskamp
Journal:  Eur J Clin Pharmacol       Date:  2005-03-11       Impact factor: 2.953

2.  Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project.

Authors:  Saif S Rathore; JoAnne Micale Foody; Yongfei Wang; Jeph Herrin; Frederick A Masoudi; Edward P Havranek; Diana L Ordin; Harlan M Krumholz
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

Review 3.  Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.

Authors:  Flavia Franconi; Ilaria Campesi
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland.

Authors:  N F Murphy; C R Simpson; F A McAlister; S Stewart; K MacIntyre; M Kirkpatrick; J Chalmers; A Redpath; S Capewell; J J V McMurray
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

5.  Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program.

Authors:  Flavia Franconi; Stefano Omboni; Ettore Ambrosioni; Giorgio Reggiardo; Ilaria Campesi; Claudio Borghi
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.